Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.D. Lee is active.

Publication


Featured researches published by M.D. Lee.


Transplantation Proceedings | 2011

High Mortality Associated With Acinetobacter Species Infection in Liver Transplant Patients

Young-Yul Kim; Jung Han Yoon; Sang Il Kim; Kyung Wook Hong; J.I. Kim; Jah Yeon Choi; S.K. Yoon; Y.K. You; M.D. Lee; I.S. Moon; D.G. Kim; M.W. Kang

BACKGROUND Acinetobacter species have become increasingly important nosocomial pathogens worldwide and can result in a wide range of infections, including bacteremia, pneumonia, urinary tract infection, peritonitis, among others. The aim of this study was to investigate clinical characteristics, mortality, and outcomes among liver transplant recipients with Acinetobacter species infections. METHODS We retrospectively analyzed 451 subjects who had undergone living donor liver transplantations between January 2001 and May 2010. Pandrug-resistant (PDR) Acinetobacter species were defined as resistant to all commercially available antibiotics except colistin. RESULTS Infectious complications due to Acinetobacter species appeared in 26 patients (5.8%) with a total of 37 episodes. Of the species identified, 34 were Acinetobacter baumannii and 3 Acinetobacter Iwoffiii. The presumed sources of infection were the biliary tract (n = 21, 56.8%), lung (n = 7, 18.9%), intra-abdomen (n = 6, 16.2%), catheter (n = 2, 5.4%), and urinary tract (n = 1, 3.6%). Among the 37 Acinetobacter species, 75.7% (28/37) were PDR species. Age, duration of intensive care unit stay, Child-Pugh score, and Model for End-stage Liver Disease score were not significant risk factors for Acinetobacter species infection. However, the overall mortality among patients with Acinetobacter species infections was 50% (13/26), which was significantly higher than that among those free of infection (50% vs 11.5%, P < .05). Multivariate analysis using a Cox regression model showed that inappropriate antimicrobial treatment was a significant independent risk factor for mortality among patients with Acinetobacter species infections (hazard Ratio = 4.19, 95% confidence interval 1.1-18.7; P = .06). CONCLUSION Patients with Acinetobacter species infections after liver transplantation show a significantly worse prognosis. PDR Acinetobacter species have been a major problem in our center.


Transplantation Proceedings | 2008

Surgical Techniques According to Anatomic Variations in Living Donor Liver Transplantation Using the Right Lobe

Kiyoun Lee; Song Lee; I.S. Moon; D.G. Kim; M.D. Lee

OBJECTIVES In living donor liver transplantation, the right lobe has many anatomic variations in the vascular tree, which could lead to surgical complications. We need to define surgical technique according to anatomy. METHODS From January 2000 to September 2007, 310 living donor liver transplantations using the right lobe were performed in patients with end-stage liver disease. The vascular trees were evaluated preoperatively with computed tomography and magnetic resonance angiography. We classified anatomic points for safe harvest in the hepatic artery, portal vein, and hepatic vein and described technical points based on anatomic variations. RESULT There were many anatomic variations in the hepatic vasculature. Hepatic artery variations were observed in 16.8% of cases. Double hepatic artery was observed in 14 cases (4.5%). Of these 14 cases, reconstruction as a single artery was performed in 6 and dual reconstruction was performed in 8 cases. Portal vein variation was observed in 45 cases (14.5%): Dual anastomosis to right and left portal vein was performed in type III (n = 20; 6.4%) and type IV (n = 3; 1.0%) variations. There were 70 cases of portal vein thrombosis. In 8 of the 70, a jump or interposition graft with iliac vein was utilized. Of the middle hepatic vein variant, segment V vein only was reconstructed in 188 (60.6%) cases. In 21 (6.8%) cases, segment VIII vein only was reconstructed, and in 43 (13.9%) cases, both segment V and segment VIII veins were reconstructed using the recipients portal vein, a cryopreserved iliac vein, or a prosthetic graft. The most common variation of right inferior hepatic vein was type II (n = 141; 45.5%), which has 1 right inferior hepatic vein. CONCLUSION Living donor liver transplantation using the right lobe can be performed safely, but there is a potential operative risk because of various anatomic variations. To minimize operative complications, anatomic variations should be kept in mind to ensure a safe and successful operation.


Clinical Transplantation | 2011

Clinical analysis of living donor liver transplantation in patients with portal vein thrombosis

Say-June Kim; Dong-Goo Kim; Jung-Hyun Park; In-Sung Moon; M.D. Lee; Ji-Il Kim; Y. C. Yoon; Young-Kyung Yoo

Kim S‐J, Kim D‐G, Park J‐H, Moon I‐S, Lee M‐D, Kim J‐I, Yoon Y‐C, Yoo Y‐K. Clinical analysis of living donor liver transplantation in patients with portal vein thrombosis.
Clin Transplant 2011: 25: 111–118.


Transplantation Proceedings | 2012

Chronic Rejection in a Small Bowel Transplant with Successful Revision of the Allograft by Segmental Resection: Case Report

S.Y. Kim; D.G. Kim; I.S. Moon; Sang Il Kim; J.I. Kim; Sun Im; Eun-Sun Jung; Jeong Mi Park; M.D. Lee

An 8-year-old girl was admitted for severe electrolyte imbalance and for hyponatremic seizure. In July 2005, at 3 years of age, she underwent isolated small-bowel transplantation of 100 cm ileum from her father. Her own bowel was only 50 cm of proximal jejunum which had been directly connected to the anus due to extended total aganglionosis. The graft was placed into the middle of her remaining bowel, using the splenic artery and vein as feeding vessels with saving of the spleen. Daclizumab induction and tacrolimus monotherapy were applied for immunosuppression. Two acute cellular rejection episodes, E on day 10 and 4 years after transplantation, were successfully treated with OKT-3 and recombinant antithymocyte globulin, respectively. However, because of intermittent bowel dysfunction, she was hospitalized several times for hydration and metabolic care. On admission, her abdomen was moderately distended, and a simple abdominal film showed a fixed dilated loop. Colonoscopy could not pass the narrowed lumen, with stiffness at the anastomosis between the graft and the distal bowel. Endoscopic biopsy at the entrance to the stricture showed a nonspecific inflammatory reaction with fibrosis. Similar findings on a gastrograffin enema suggested chronic rejection (CR). On laparotomy, an irregularly narrowed fibrotic loop was noticed at the distal part of the graft, proximal to the anastomosis. We performed a 20-cm segmental resection with an end-to-end anastomosis. Histopathologic findings showed CR with fibrosis and hyalinization of the entire bowel wall and vessel walls with mild cellular infiltrations. She recovered in 10 days. The graft may have been saved, but intermittent requirement of hydration over the following months suggested progressive graft dysfunction. A case of segmental involvement of CR with subsequent successful graft salvage by partial resection is rare in the literature.


Transplantation Proceedings | 2016

Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital

H.K. Chang; S.Y. Kim; J.I. Kim; Sang Il Kim; J.K. Whang; Jong Young Choi; Jeong Mi Park; Eun-Sun Jung; Sung Eun Rha; D.G. Kim; I.S. Moon; M.D. Lee

A retrospective review of intestinal transplantation (ITx) at Seoul St. Marys Hospital was made by collecting clinical data over the past 10 years. Fifteen consecutive cases from 2004 were analyzed. Five children and 10 adults (6 months to 69 years of age) were included. Primary diseases in adults included 4 mesenteric vessel thromboses, 2 strangulations, and 1 each of visceral myopathy, malignant gastrointestinal stromal tumor (GIST), mesenteric lymphangiectasis, and injury. Pediatric cases involved 2 Hirschsprung disease, 2 visceral myopathy, and 1 necrotizing enterocolitis. Three of 7 stomas were closed using a serial transverse enteroplasty procedure before transplantation. The ITx were performed using 3 living-donor Itx, 12 deceased-donor ITx, 14 isolated Itx, and 1 modified multivisceral transplantation. Daclizumab, basiliximab, alemtusumab, or basiliximab with rabbit antithymocyte globulin (rATG) was used for the induction; tacrolimus monotherapy was used as the basic maintenance immunosuppressant; and m-TOR inhibitor was used for renal dysfunction patients. Seven cases of acute cellular rejection were treated with rATG. Three cases of antibody-mediated rejection were treated with rituximab alone or with rituximab and bortezomib combination. There were 4 cases of early mortality within 6 months after Itx. Causes of death were declamping shock, cardiac tamponade with acute cellular rejection, dysmotility, and sepsis. Surgical complications consisted of 1 feeding jejunostomy displacement, and a minor leakage at a colo-colostomy site. One-year survival of the patient and graft was 73.33% (Kaplan-Meier survival curve). Although the total number of ITx is small, its social impact has been remarkable in changing the related laws and reimbursement policy in Korea.


American Journal of Medical Genetics Part A | 2018

A missense mutation in EBF2 was segregated with imperforate anus in a family across three generations

Shinn Young Kim; Hyun Sun Ko; Namshin Kim; Seon-Hee Yim; Seung-Hyun Jung; Jiwoong Kim; M.D. Lee; Yeun-Jun Chung

The etiology of imperforate anus, a major phenotype of anorectal malformation (ARM), is still unknown and not a single gene has been reported to be associated with it. We studied a Korean family with six affected members with imperforate anus across three generations by whole exome sequencing and identified a missense mutation in the EBF2 gene (c.215C > T; p.Ala72Val). This mutation is completely segregated with the disease phenotype in the family and is evolutionarily highly conserved among diverse vertebrates. Also, this mutation was predicted to be functionally damaging. These results support that missense mutation in the EBF2 c.215C > T (p.Ala72Val) is very likely to contribute to the pathogenesis of ARM in this family.


Medical Physics | 2016

TU-AB-BRA-04: An Investigation of Metal Artifact Effects in Multi-Modalities: Development of MRI-CT Heterogeneous Head and Neck Phantom for MRI-CT Registration

M.D. Lee; Kyung Sup Song; Bo-Young Choe; Tae-Suk Suh

PURPOSE The purpose of this investigation was to develop an CT-MR head and neck phantom which can investigate dose calculation differences between density-assigned MRI and CT, and to compare non-implant inserted registered MR-CT registered image with artifact reduced image of MR-CT registered image. It is to identify potential limitations related to dental implants of MR image and CT image and maximize the advantages to find interactive method to use registered image. METHODS The phantom comprises half-circled shape which shaped to simulated the anatomical structures of a human head and neck. Through applying various clinical cases, the developed phantom is closely allied to human. Developed phantom can be verified in to opened-mouth and closed-mouth phantom. The case of the phantom was made of acrylic, which introduces a 0.003 parts per million (ppm) phase shift, whereas the Teflon results in a 0.03 ppm shift measured at 3T which represents human bone. Both materials are considered acceptable for MR field measurements. The phantom was filled with a solution of nickel chloride and sodium chloride. The implants and teeth were imaged by means of 3T MRI system. RESULTS In MRI image, the metal artifact reduced and the results in improved image quality and reduction of susceptibility artifacts originate in MR images. CT and MR artifact correction method resulted in substantial artifact reduction, both quantitatively and qualitatively. On head and neck CT images, it remained anatomical conformation but it has reduced streak and dark artifact which appeared around the dental restoration. The artifact reduced MR-CT image improved image quality and calculation accuracy for patients with severe CT artifacts. CONCLUSION By using MRI/CT and the artifact-free slice location of the phantom, we demonstrated that the proposed artifact reduction method can effectively remove streak artifacts from a metal object.


Medical Physics | 2016

SU-G-BRB-01: A Novel 3D Printed Patient-Specific Phantom for Spine SBRT Quality Assurance: Comparison of 3D Printing Techniques

Sung Sook Lee; Myung-Suk Kim; M.D. Lee; Tae-Suk Suh

PURPOSE The novel 3 dimensional (3D)-printed spine quality assurance (QA) phantoms generated by two different 3D-printing technologies, digital light processing (DLP) and Polyjet, were developed and evaluated for spine stereotactic body radiation treatment (SBRT). METHODS The developed 3D-printed spine QA phantom consisted of an acrylic body and a 3D-printed spine phantom. DLP and Polyjet 3D printers using the high-density acrylic polymer were employed to produce spine-shaped phantoms based on CT images. To verify dosimetric effects, the novel phantom was made it enable to insert films between each slabs of acrylic body phantom. Also, for measuring internal dose of spine, 3D-printed spine phantom was designed as divided laterally exactly in half. Image fusion was performed to evaluate the reproducibility of our phantom, and the Hounsfield unit (HU) was measured based on each CT image. Intensity-modulated radiotherapy plans to deliver a fraction of a 16 Gy dose to a planning target volume (PTV) based on the two 3D-printing techniques were compared for target coverage and normal organ-sparing. RESULTS Image fusion demonstrated good reproducibility of the fabricated spine QA phantom. The HU values of the DLP- and Polyjet-printed spine vertebrae differed by 54.3 on average. The PTV Dmax dose for the DLP-generated phantom was about 1.488 Gy higher than for the Polyjet-generated phantom. The organs at risk received a lower dose when the DLP technique was used than when the Polyjet technique was used. CONCLUSION This study confirmed that a novel 3D-printed phantom mimicking a high-density organ can be created based on CT images, and that a developed 3D-printed spine phantom could be utilized in patient-specific QA for SBRT. Despite using the same main material, DLP and Polyjet yielded different HU values. Therefore, the printing technique and materials must be carefully chosen in order to accurately produce a patient-specific QA phantom.


Medical Physics | 2015

SU-E-T-647: Quality Assurance of VMAT by Gamma Analysis Dependence On Low-Dose Threshold

Jin Ho Song; Myung-Suk Kim; S.-H. Park; Sung Sook Lee; M.D. Lee; Tae-Suk Suh

Purpose: The AAPM TG-119 instructed institutions to use low-dose threshold (LDT) of 10% or a ROI determined by the jaw when they collected gamma analysis QA data of planar dose distribution. Also, based on a survey by Nelms and Simon, more than 70% of institutions use a LDT between 0% and 10% for gamma analysis. However, there are no clinical data to quantitatively demonstrate the impact of the LDT on the gamma index. Therefore, we performed a gamma analysis with LDTs of 0% to 15% according to both global and local normalization and different acceptance criteria: 3%/3 mm, 2%/2 mm, and 1%/1 mm. Methods: A total of 30 treatment plans—10 head and neck, 10 brain, and 10 prostate cancer cases—were randomly selected from the Varian Eclipse TPS, retrospectively. For the gamma analysis, a predicted portal image was acquired through a portal dose calculation algorithm in the Eclipse TPS, and a measured portal image was obtained using a Varian Clinac iX and an EPID. Then, the gamma analysis was performed using the Portal Dosimetry software. Results: For the global normalization, the gamma passing rate (%GP) decreased as the LDT increased, and all cases of low-dose thresholds exhibited a %GP above 95% for both the 3%/3 mm and 2%/2 mm criteria. However, for local normalization, the %GP increased as LDT increased. The gamma passing rate with LDT of 10% increased by 6.86%, 9.22% and 6.14% compared with the 0% in the case of the head and neck, brain and prostate for 3%/3 mm criteria, respectively. Conclusion: Applying the LDT in the global normalization does not have critical impact to judge patient-specific QA results. However, LDT for the local normalization should be carefully selected because applying the LDT could affect the average of the %GP to increase rapidly.


Medical Physics | 2014

SU-E-T-160: Evaluation of Accuracy for Target Margin Size Obtained From CBCT On Lung SBRT Based On Film Dosimetry

Sung Sook Lee; J Park; S.-H. Park; M.D. Lee; Myung-Suk Kim; Tae-Suk Suh

PURPOSE To analysis delivered dose on target using gafchromic films for evaluating accuracy of target margin size obtained from cone beam computed tomography (CBCT) during lung stereotactic body radiation therapy (SBRT) METHODS: The phantom consists of measurement part and driving part. The motor of Quasar motion phantom (Modus Medical Devices Inc, London, ON, Canada) was used for driving part and we developed measurement part which consist of cork cylindrical body and acrylic target with radiochromic film inserted into central and both ends of acrylic target. In this study lung SBRT cases through both four dimensional computed tomography (4DCT) and CBCT were selected. Target contouring including margin based on 4DCT is defined with a 1 cm margin around gross tumor volume (GTV) in all directions except for inferior direction. The moving range in inferior direction was larger than other directions thus, including 2 cm margin. In case of CBCT, the margin means blurring of target on CBCT images. This study was compared margin size determined through 4DCT and that of based on CBCT and we also evaluated dose profile and the length of margin in superior-inferior direction on CBCT compared with 4DCT. RESULTS The length of target including margin was 2.48 cm (based on CBCT) and 2.66 cm (based on 4DCT), respectively in superior-inferior direction. The difference of delivered dose on target between two margins was only within 1%. CONCLUSIONS This study has shown the feasibility of determining target margin using CBCT for delivering more accurate prescription dose to lung cancer.

Collaboration


Dive into the M.D. Lee's collaboration.

Top Co-Authors

Avatar

In-Sung Moon

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Dong Goo Kim

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Sun-Cheol Park

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

D.G. Kim

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

I.S. Moon

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Jeong-Kye Hwang

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

M. Kim

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

Sang Il Kim

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar

K. Jun

Catholic University of Korea

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge